Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Ann Epidemiol. 2008 Sep;18(9):671–677. doi: 10.1016/j.annepidem.2008.06.006

Table 2.

Baseline characteristics (mean (standard deviation), or percent) of the ARIC cohort stratified by menopausal and exposure status

Characteristic Pre-menopausal
(n=2,217)
Post-menopausal
(n=4,441)

Exposure status Exposure status

Total Exposed (n=735) Unexposed (n=1,482) Total Exposed (n=1,582) Unexposed (n=2,859)
(HDL-C<50 mg/dL) (HDL-C≥50 mg/dL) (HDL-C<50 mg/dL) (HDL-C≥50 mg/dL)
Age 49.1 (3.4) 48.9 (3.3) 49.2 (3.5) 56.7 (4.9) 56.8 (5.0) 56.7 (4.9)
Race, % White 77.7 77.8 77.6 70.8 72.1 70.1
Smoking status:
  Current (%) 21.1 30.1 16.6 25.3 31.4 21.9
  Former (%) 34.4 18.6 27.2 21.7 18.7 23.4
  Never (%) 54.6 51.3 56.2 53.0 49.9 54.8
HDL-cholesterol mg/dL 57.9 (16.3) 41.2 (6.1) 66.2 (13.2) 57.8 (17.6) 41.1 (6.2) 67.1 (14.8)
High triglycerides (≥150 mg/dL, %) 15.3 32.2 6.9 26.8 48.7 14.7
Triglycerides (mg/dL) 105.8 (71.4) 142.0 (100.5) 87.9 (40.6) 130.8 (81.8) 173.5 (105.6) 107.2 (91.5)
Medication primarily lowering 0.9 2.6 0.7 3.7 5.7 3.5
cholesterol (%)
All cholesterol lowering medication (%) 19.3 29.7 17.9 30.7 43.3 28.7
Body mass index 27.5 (6.3) 30.0 (6.7) 26.3 (5.7) 27.9 (6.0) 29.7 (5.9) 26.9 (5.8)
Waist hip ratio 0.88 (0.08) 0.91 (0.08) 0.86 (0.08) 0.91 (0.08) 0.94 (0.07) 0.89 (0.08)
Diabetes, % 7.0 12.7 4.1 12.4 21.1 7.5
Education, (% less than high school) 13.9 16.7 12.4 27.3 32.6 24.3
Average age at menarche 12.9 (1.8) 12.8 (1.6) 12.9 (2.0) 12.9 (1.7) 13.0 (1.7) 12.9 (1.7)
Average age at menopause - - - 45.2 (1.7) 45.1 (6.5) 45.2 (6.4)
Average number of live births 3.1 (1.8) 3.2 (1.7) 3.0 (1.8) 3.4 (2.2) 3.5 (2.2) 3.3 (2.1)
Use of hormone replacement therapy
Current Estrogen (%) 3.8 2.0 4.7 17.0 9.5 21.2
Current Estrogen+Progesterone (%) 10.8 5.9 13.3 3.6 1.8 4.7
Never (%) 74.3 79.9 71.5 59.1 67.9 54.2
Former (%) 8.3 9.5 7.6 17.0 17.7 16.6